日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: A systematic review and meta-analysis

新冠肺炎合并消化系统肿瘤成年住院患者的病死率:系统评价和荟萃分析

Wang, Guoqun; Pan, Lanlan; Zhao, Jianyi; Tang, Jie; Fang, Yueyu; Sun, Hui; Seesaha, Poshita Kumari; Chen, Wensen; Chen, Xiaofeng

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer

胆道癌免疫检查点抑制剂的最新进展和未来展望

Seesaha, Poshita-Kumari; Wang, Kang-Xin; Wang, Guo-Qun; Cui, Ting-Yun; Zhao, Feng-Jiao; Pan, Lan-Lan; Li, Xiang-Cheng; Shu, Yong-Qian; Chen, Xiao-Feng

Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial

卡瑞利珠单抗联合吉西他滨和奥沙利铂(GEMOX)治疗晚期胆道癌患者:一项单臂、开放标签的II期试验

Chen, Xiaofeng; Wu, Xiaofeng; Wu, Hao; Gu, Yanhong; Shao, Yang; Shao, Qianwen; Zhu, Feipeng; Li, Xiao; Qian, Xiaofeng; Hu, Jun; Zhao, Fengjiao; Mao, Weidong; Sun, Jing; Wang, Jian; Han, Gaohua; Li, Changxian; Xia, Yongxiang; Seesaha, Poshita Kumari; Zhu, Dongqin; Li, Huajun; Zhang, Junling; Wang, Guoqiang; Wang, Xuehao; Li, Xiangcheng; Shu, Yongqian